🔎 Trials Near Me

Home › NCT03667599

A Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation

Recruiting

A Randomized Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation

Who can join

Ages 18 to 80 · All sexes

Full eligibility criteria
Patient Inclusion Criteria:

* Scheduled to undergo an autologous hematopoietic stem cell transplant for any cancer or non-cancer illness
* Age 18-80 years
* Karnofsky Performance Scale KPS\> 80
* Able to read/write English
* A home that is deemed, upon inspection, in suitable condition to serve as a medical home, within a 90-minute driving distance of Duke

Patient Exclusion Criteria:

* Lack of a caregiver
* Pregnant women
* Patients with a documented active infection prior to starting their preparative regimen. This includes grade 3 or higher viral, bacterial, or fungal infection.
* Use of homeopathic medications, prebiotics, or probiotics that may impact gut microbiota

Caregiver Inclusion Criteria:

* Identified by patient as their primary caregiver
* Meet standard clinical criteria for being a caregiver (able to drive and take care of patient)
* Age 18-80 years

Caregiver Exclusion Criteria:

None

About the study

This is a research study to compare the well-being (caregiver strain index) of caregivers of patients receiving home vs standard care after autologous hematopoietic stem cell transplant.

What is being tested

Sponsor: Duke University · Participants: 150 · Started: Sep 28, 2018

Contact the study team

Official record on ClinicalTrials.gov — NCT03667599

Locations in the U.S.

North CarolinaDuke University Medical Center, Durham

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.